Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference
Kyverna Therapeutics (NASDAQ: KYTX), a clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases, announced that CEO Warner Biddle will present at the Jefferies Global Healthcare Conference in New York. The presentation is scheduled for June 4, 2025, at 4:55 p.m. ET. Investors can access the live webcast through Kyverna's investor relations website at ir.kyvernatx.com, with a replay available for 30 days after the event.
[]Kyverna Therapeutics (NASDAQ: KYTX), un'azienda biofarmaceutica in fase clinica che sviluppa terapie cellulari per malattie autoimmuni, ha annunciato che il CEO Warner Biddle parteciperà alla Jefferies Global Healthcare Conference a New York. La presentazione è prevista per il 4 giugno 2025 alle 16:55 ET. Gli investitori potranno seguire la diretta streaming tramite il sito web delle relazioni con gli investitori di Kyverna all'indirizzo ir.kyvernatx.com, con una replica disponibile per 30 giorni dopo l'evento.
Kyverna Therapeutics (NASDAQ: KYTX), una empresa biofarmacéutica en etapa clínica que desarrolla terapias celulares para enfermedades autoinmunes, anunció que el CEO Warner Biddle presentará en la Jefferies Global Healthcare Conference en Nueva York. La presentación está programada para el 4 de junio de 2025 a las 4:55 p.m. ET. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de Kyverna en ir.kyvernatx.com, con una repetición disponible durante 30 días después del evento.
Kyverna Therapeutics (NASDAQ: KYTX)는 자가면역 질환을 위한 세포 치료제를 개발하는 임상 단계의 바이오제약 회사로, CEO 워너 비들( Warner Biddle)이 뉴욕에서 열리는 Jefferies Global Healthcare Conference에서 발표할 예정이라고 발표했습니다. 발표 일정은 2025년 6월 4일 오후 4시 55분(동부 시간)입니다. 투자자들은 Kyverna의 투자자 관계 웹사이트 ir.kyvernatx.com을 통해 생중계에 접속할 수 있으며, 행사 후 30일 동안 다시보기 서비스도 제공됩니다.
Kyverna Therapeutics (NASDAQ : KYTX), une société biopharmaceutique en phase clinique développant des thérapies cellulaires pour les maladies auto-immunes, a annoncé que le PDG Warner Biddle présentera lors de la Jefferies Global Healthcare Conference à New York. La présentation est prévue pour le 4 juin 2025 à 16h55 ET. Les investisseurs pourront accéder à la diffusion en direct via le site des relations investisseurs de Kyverna à l'adresse ir.kyvernatx.com, avec un replay disponible pendant 30 jours après l'événement.
Kyverna Therapeutics (NASDAQ: KYTX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das Zelltherapien für Autoimmunerkrankungen entwickelt, gab bekannt, dass CEO Warner Biddle auf der Jefferies Global Healthcare Conference in New York präsentieren wird. Die Präsentation ist für den 4. Juni 2025 um 16:55 Uhr ET geplant. Investoren können den Live-Webcast über die Investor-Relations-Website von Kyverna unter ir.kyvernatx.com verfolgen, mit einer Wiederholung, die 30 Tage nach der Veranstaltung verfügbar ist.
- None.
- None.
A live webcast of the presentation may be accessed via the Investors section of the Kyverna website at ir.kyvernatx.com. A replay of the webcast will be available on the website for 30 days following the conference.
About Kyverna Therapeutics
Kyverna Therapeutics, Inc. (Nasdaq: KYTX) is a clinical-stage biopharmaceutical company focused on liberating patients through the curative potential of cell therapy. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through late-stage clinical development with registrational trials for stiff person syndrome and myasthenia gravis, and two ongoing multi-center Phase 1/2 trials for patients with lupus nephritis. The Company is also harnessing other KYSA trials and investigator-initiated trials, including in multiple sclerosis, to inform the next priority indications for the Company to advance into late-stage development. Its pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases. For more information, please visit https://kyvernatx.com.
Contact:
Investors: InvestorRelations@kyvernatx.com
Media: media@kyvernatx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/kyverna-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-302467131.html
SOURCE Kyverna Therapeutics
FAQ
When is Kyverna Therapeutics (KYTX) presenting at the Jefferies Healthcare Conference 2025?
Who will represent Kyverna Therapeutics (KYTX) at the Jefferies Conference 2025?
How can investors watch Kyverna Therapeutics' (KYTX) Jefferies Conference presentation?
What is Kyverna Therapeutics' (KYTX) main business focus?
